After the transaction, Baker Bros Advisors LLC's stake was reported as 10,117,174 shares of Genomic Health Inc stock.
As noted on November 23, 2012, Baker Bros Advisors LLC's purchase was done indirectly through "See Footnotes" over 6 transactions from November 20, 2012 to November 21, 2012. The share price ranged from $26.83 to $27.54 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Baker Bros Advisors LLC has sold no shares of Genomic Health Inc stock. Over the same time period, Baker Bros Advisors LLC has purchased 229,300 shares of Genomic Health Inc, with a total cost of $6,151,622.
Let's take a quick, high-level look at insider trading at Genomic Health Inc over the past 12 months. A total of 489,515 shares of Genomic Health Inc stock was sold by insiders, totaling $14,961,271. Over the same time 12 month time period, 3,816,521 shares of Genomic Health Inc, for a total value of $110,008,763 were purchased by company insiders.
To view the complete SEC Filing: Genomic Health Inc Form 4 (Insider Trading) SEC Filing
